|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amaravadi RK and Thompson CB: The roles of
therapy-induced autophagy and necrosis in cancer treatment. Clin
Cancer Res. 13:7271–7279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee YJ and Jang BK: The role of autophagy
in hepatocellular carcinoma. Int J Mol Sci. 16:26629–26643. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amaravadi RK, Lippincott-Schwartz J, Yin
XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT and White E:
Principles and current strategies for targeting autophagy for
cancer treatment. Clin Cancer Res. 17:654–666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chiang HL and Dice JF: Peptide sequences
that target proteins for enhanced degradation during serum
withdrawal. J Biol Chem. 263:6797–6805. 1988.PubMed/NCBI
|
|
7
|
Xilouri M, Brekk OR, Kirik D and Stefanis
L: LAMP2A as a therapeutic target in Parkinson disease. Autophagy.
9:2166–2168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fidziańska A, Walczak E and Walski M:
Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a
boy with Danon disease. Folia Neuropathol. 45:133–139. 2007.
|
|
9
|
Venugopal B, Mesires NT, Kennedy JC,
Curcio-Morelli C, Laplante JM, Dice JF and Slaugenhaupt SA:
Chaperone-mediated autophagy is defective in mucolipidosis type IV.
J Cell Physiol. 219:344–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cuervo AM and Dice JF: Regulation of
lamp2a levels in the lysosomal membrane. Traffic. 1:570–583. 2000.
View Article : Google Scholar
|
|
11
|
Cuervo AM, Knecht E, Terlecky SR and Dice
JF: Activation of a selective pathway of lysosomal proteolysis in
rat liver by prolonged starvation. Am J Physiol. 269:C1200–C1208.
1995.PubMed/NCBI
|
|
12
|
Cuervo AM and Dice JF: Unique properties
of lamp2a compared to other lamp2 isoforms. J Cell Sci.
113:4441–4450. 2000.PubMed/NCBI
|
|
13
|
Park Y, Liu C, Luo T, Dietrich WD,
Bramlett H and Hu B: Chaperone-mediated autophagy after traumatic
brain injury. J Neurotrauma. 32:1449–1457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saha T: LAMP2A overexpression in breast
tumors promotes cancer cell survival via chaperone-mediated
autophagy. Autophagy. 8:1643–1656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang C and Cuervo AM: Restoration of
chaperone-mediated autophagy in aging liver improves cellular
maintenance and hepatic function. Nat Med. 14:959–965. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai
Z, Shi GM, Wang XY, Ke AW, Wu B, et al: Association of autophagy
defect with a malignant phenotype and poor prognosis of
hepatocellular carcinoma. Cancer Res. 68:9167–9175. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hui B, Shi YH, Ding ZB, Zhou J, Gu CY,
Peng YF, Yang H, Liu WR, Shi GM and Fan J: Proteasome inhibitor
interacts synergistically with autophagy inhibitor to suppress
proliferation and induce apoptosis in hepatocellular carcinoma.
Cancer. 118:5560–5571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding ZB, Hui B, Shi YH, Zhou J, Peng YF,
Gu CY, Yang H, Shi GM, Ke AW, Wang XY, et al: Autophagy activation
in hepatocellular carcinoma contributes to the tolerance of
oxaliplatin via reactive oxygen species modulation. Clin Cancer
Res. 17:6229–6238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke
AW, Wang XY, Dai Z, Peng YF, Gu CY, et al: Targeting autophagy
enhances sorafenib lethality for hepatocellular carcinoma via ER
stress-related apoptosis. Autophagy. 7:1159–1172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY,
Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition
suppresses pulmonary metastasis of HCC in mice via impairing
anoikis resistance and colonization of HCC cells. Autophagy.
9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY,
Xiao YS, Xu Y, Li YW and Tang ZY: Intratumoral balance of
regulatory and cytotoxic T cells is associated with prognosis of
hepatocellular carcinoma after resection. J Clin Oncol.
25:2586–2593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaushik S, Bandyopadhyay U, Sridhar S,
Kiffin R, Martinez-Vicente M, Kon M, Orenstein SJ, Wong E and
Cuervo AM: Chaperone-mediated autophagy at a glance. J Cell Sci.
124:495–499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lebovitz CB, Bortnik SB and Gorski SM:
Here, there be dragons: Charting autophagy-related alterations in
human tumors. Clin Cancer Res. 18:1214–1226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiang HL, Terlecky SR, Plant CP and Dice
JF: A role for a 70-kilodalton heat shock protein in lysosomal
degradation of intracellular proteins. Science. 246:382–385. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cuervo AM and Dice JF: A receptor for the
selective uptake and degradation of proteins by lysosomes. Science.
273:501–503. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Massey AC, Kaushik S, Sovak G, Kiffin R
and Cuervo AM: Consequences of the selective blockage of
chaperone-mediated autophagy. Proc Natl Acad Sci USA.
103:5805–5810. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schneider JL, Villarroya J, Diaz-Carretero
A, Patel B, Urbanska AM, Thi MM, Villarroya F, Santambrogio L and
Cuervo AM: Loss of hepatic chaperone-mediated autophagy accelerates
proteostasis failure in aging. Aging Cell. 14:249–264. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schneider JL, Suh Y and Cuervo AM:
Deficient chaperone-mediated autophagy in liver leads to metabolic
dysregulation. Cell Metab. 20:417–432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Finkel T, Serrano M and Blasco MA: The
common biology of cancer and ageing. Nature. 448:767–774. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kon M, Kiffin R, Koga H, Chapochnick J,
Macian F, Varticovski L and Cuervo AM: Chaperone-mediated autophagy
is required for tumor growth. Sci Transl Med. 3:109ra1172011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou J, Yang J, Fan X, Hu S, Zhou F, Dong
J, Zhang S, Shang Y, Jiang X, Guo H, et al: Chaperone-mediated
autophagy regulates proliferation by targeting RND3 in gastric
cancer. Autophagy. 12:515–528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hait WN, Jin S and Yang JM: A matter of
life or death (or both): Understanding autophagy in cancer. Clin
Cancer Res. 12:1961–1965. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cicchini M, Karantza V and Xia B:
Molecular pathways: Autophagy in cancer - a matter of timing and
context. Clin Cancer Res. 21:498–504. 2015. View Article : Google Scholar
|
|
35
|
Hubbi ME, Hu H, Kshitiz, Ahmed I,
Levchenko A and Semenza GL: Chaperone-mediated autophagy targets
hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation. J
Biol Chem. 288:10703–10714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sherman M: Recurrence of hepatocellular
carcinoma. N Engl J Med. 359:2045–2047. 2008. View Article : Google Scholar : PubMed/NCBI
|
